Optimizing a clinical guidance for diagnosis of atopic dermatitis in adults: joint recommendations of the Italian Society of Dermatology and Venereology (SIDeMaST), Italian Association of Hospital Dermatologists (ADOI), and Italian Society of Allergological, Occupational and Environmental Dermatolog

Atopic dermatitis (AD) places significant burden not only on quality of life, but is also associated with considerable costs to healthcare systems. Diagnosis of AD may be challenging when it starts in adolescence or adulthood, and is further complicated as its manifestations are different from those generally seen in children. Accordingly, better definition of diagnostic criteria for adult onset AD is needed to avoid misdiagnosis and undertreatment in adult patients. To provide practical guidance for clinicians to reliably diagnose AD in adult patients, representatives from three Italian dermatology scientific societies [Italian Society of Dermatology and Venereology (SIDeMaST), Italian Association of Hospital Dermatologists (ADOI), Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA)] carried out a joint consensus meeting to develop useful indications for improving diagnosis of moderate to severe AD in adult patients in routine clinical practice. The most representative criteria for morphological criteria, localization, clinical history, and differential diagnosis were identified by the experts. The most frequent clinical presentations are those on the flexural areas, hands, face/neck, and trunk, with itch and eczema as key manifestations. The diagnostic path defined herein can form a sort of 'check list' for physicians to adopt when evaluating patients with suspected AD, which can help in refining a diagnosis and refer the patient for specialist dermatological care. It is hoped that the practical guidance developed by the consensus group will help to improve outcomes, lower overall costs of care, and ameliorate the patient's quality of life, even though validation in a large cohort of patients is still needed.

[1]  A. Armstrong,et al.  Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2 , 2020, The Journal of dermatological treatment.

[2]  G. Fabbrocini,et al.  Allergic contact dermatitis in patients with atopic dermatitis: A retrospective study. , 2019, The journal of allergy and clinical immunology. In practice.

[3]  J. Silverberg,et al.  A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis. , 2019, Journal of the American Academy of Dermatology.

[4]  J. Silverberg,et al.  Association between atopic dermatitis, depression, and suicidal ideation: A systematic review and meta-analysis. , 2019, Journal of the American Academy of Dermatology.

[5]  D. Margolis,et al.  Epidemiology of atopic dermatitis in adults: Results from an international survey , 2018, Allergy.

[6]  A. Muraro,et al.  Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7]  P. Amerio,et al.  Atopic dermatitis treatment: what's new on the horizon? , 2018, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[8]  M. Megna,et al.  An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease , 2017, Archives of Dermatological Research.

[9]  Y. Ohya,et al.  Japanese guidelines for atopic dermatitis 2017. , 2017, Allergology international : official journal of the Japanese Society of Allergology.

[10]  M. Worm,et al.  Dupilumab in the treatment of moderate-to-severe atopic dermatitis , 2017, Expert review of clinical immunology.

[11]  A. Kanwar.  Adult-onset Atopic Dermatitis , 2016, Indian journal of dermatology.

[12]  Y. Kataoka,et al.  Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016 , 2016, The Journal of dermatology.

[13]  J. Silverberg,et al.  Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. , 2016, The New England journal of medicine.

[14]  J. Ring,et al.  ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[15]  Ping Liu,et al.  Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis , 2016, Chinese medical journal.

[16]  T. Bieber,et al.  Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults. , 2016, Journal of the American Academy of Dermatology.

[17]  A. Néel,et al.  Dermatite atopique de l’adulte , 2016 .

[18]  J. Silverberg,et al.  Association between Atopic Dermatitis and Depression in US Adults. , 2015, The Journal of investigative dermatology.

[19]  C. Bindslev‐Jensen,et al.  Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities , 2015, Allergy. European Journal of Allergy and Clinical Immunology.

[20]  S. Nutten.  Atopic Dermatitis: Global Epidemiology and Risk Factors , 2015, Annals of Nutrition and Metabolism.

[21]  L. Misery,et al.  The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries , 2014, The Journal of investigative dermatology.

[22]  R. Fölster-Holst.  Management of atopic dermatitis: are there differences between children and adults? , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[23]  S. Feldman,et al.  Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. , 2014, Journal of the American Academy of Dermatology.

[24]  J. Schmitt,et al.  Nonallergic comorbidities of atopic eczema: an overview of systematic reviews , 2014, Allergy.

[25]  T. Narang,et al.  Adult onset atopic dermatitis: Under-recognized or under-reported? , 2013, Indian dermatology online journal.

[26]  K. H. Kim.  Overview of atopic dermatitis , 2013, Asia Pacific allergy.

[27]  A. Armstrong,et al.  Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010 , 2011, PloS one.

[28]  P. Gisondi,et al.  Phenotypes of atopic dermatitis , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[29]  P. Tuchinda,et al.  Adult-onset atopic dermatitis: a cross-sectional study of natural history and clinical manifestation. , 2007, Asian Pacific journal of allergy and immunology.

[30]  R. Wanitphakdeedecha,et al.  Validation of the diagnostic criteria for atopic dermatitis in the adult Thai population. , 2007, Asian Pacific journal of allergy and immunology.

[31]  Japanese Dermatological Association Criteria for the diagnosis of atopic dermatitis , 2002 .

[32]  M. J. Bannister,et al.  Adult‐onset atopic dermatitis , 2000, The Australasian journal of dermatology.

[33]  W. Sauerbrei,et al.  Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. , 1996, Journal of clinical epidemiology.

[34]  D. Strachan,et al.  International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. , 1995, The European respiratory journal.

[35]  R. Hay,et al.  The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. , 1994, The British journal of dermatology.

[36]  R. Hay,et al.  The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation , 1994, The British journal of dermatology.

[37]  D. Strachan,et al.  The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis II. Observer variation of clinical diagnosis and signs of atopic dermatitis , 1994, The British journal of dermatology.

[38]  C. Gomar.  [The European Union of Medical Specialists (UEMS)]. , 1994, Revista espanola de anestesiologia y reanimacion.

[39]  K. Kang,et al.  Atopic Dermatitis , 1987, International journal of dermatology.

[40]  G. Rajka,et al.  Diagnostic Features of Atopic Dermatitis , 1980, Acta Dermato-Venereologica.

[41]  C. Foti,et al.  Contact allergy in children with atopic dermatitis: a retrospective study. , 2019, Endocrine, metabolic & immune disorders drug targets.

[42]  C. Patruno,et al.  Italian Guidelines in Patch Testing - adapted from the European Society of Contact Dermatitis (ESCD). , 2019, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[43]  M. Megna,et al.  Adult Atopic Dermatitis: Less Certainty, More Challenges. , 2017, Journal of investigational allergology & clinical immunology.

[44]  J F Silvestre Salvador,et al.  Atopic Dermatitis in Adults: A Diagnostic Challenge. , 2017, Journal of investigational allergology & clinical immunology.

[45]  S. Barbarot,et al.  [Atopic dermatitis of the adult]. , 2016, La Revue de medecine interne.

[46]  H. Price,et al.  Atopic dermatitis. , 2014, Pediatric clinics of North America.

[47]  M. Sato,et al.  Atopic dermatitis in adults: clinical and epidemiological considerations. , 2013, Revista da Associacao Medica Brasileira.

[48]  E. Simpson,et al.  Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. , 2011, The Journal of investigative dermatology.

[49]  J. Ring,et al.  Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. , 1997, Dermatology.

[50]  I I Lelis,et al.  [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.